Альфа-пвп: описание и особенности

In New Zealand, it is not explicitly scheduled but treated as a Class C substance due to structural similarity to controlled drugs. In animal studies, Alpha-PVP has been found to be equally potent and effective as MDPV in terms of reinforcing effects and locomotor stimulation.

Its mechanism involves inhibiting the reuptake of dopamine (DAT) and norepinephrine (NET), leading to increased synaptic concentrations. It is a molecular analogue of pyrovalerone and structurally related to MDPV (methylenedioxypyrovalerone).

Alpha-PVP acts primarily as a norepinephrine-dopamine reuptake inhibitor (NDRI), with weaker effects on serotonin transporters. Alpha-PVP and its metabolites can be detected in blood and urine postmortem.

The visual presentation is typically a loose structure of particles on a neutral background.

User reports indicate a transition from initial euphoria to distress and anxiety is common. Alpha-PVP is not explicitly scheduled under New Zealand's Misuse of Drugs Act but is controlled via structural similarity provisions.

It is specifically illegal in New South Wales, Australia, following fatal incidents involving users. Strong compulsive desire for re-dosing is a reported characteristic of Alpha-PVP use.

Acute effects in humans include euphoria, increased sociability, heightened libido, energy, and time distortion. Alpha-PVP imports into New Zealand have been primarily from China and Pakistan since 2012.

Visual appearance often includes small white or bluish translucent crystals with a shiny surface.

The substance was marketed as 'legal highs' before being banned in many regions. The chemical name alpha-pyrrolidinovalerophenone is synonymous with Alpha-PVP.

It acts as a psychostimulant with properties similar to cocaine and MDMA. Clinical manifestations of intoxication often include tachycardia (observed in 92% of cases in one study), hypertension, and hyperthermia.

The duration of high is approximately 3–5 hours for most routes of administration. Alpha-PVP is more potent than methamphetamine in some rat self-administration studies when compared to MDPV, but less potent than methamphetamine in substitution tests.

Primary causes of death linked to Alpha-PVP use include cardiac infarction and pulmonary edema.

Media reports claiming Alpha-PVP causes 'superhuman strength' or specific bizarre behaviors in all users are often sensationalized and not universally supported by clinical data. Common street names for Alpha-PVP include 'flakka', 'gravel', and 'niff'.

It was placed under a temporary nationwide ban in the United States effective February 2014. The European Union banned Alpha-PVP in 2015.

Alpha-PVP (alpha-pyrrolidinovalerophenone) is a synthetic cathinone stimulant. The 'Causeway Cannibal' case was initially linked to bath salts but later forensic evidence did not definitively confirm this link.

Alpha-PVP was originally synthesized in the 1960s but did not enter widespread illicit use until the early 2000s.